Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Moon Lake Immunotherapeutics Transaction History
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
- $826 Billion
- Q4 2024
A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 85 shares of MLTX stock, worth $3,207. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85
Previous 229,029
99.96%
Holding current value
$3,207
Previous $11.5 Billion
99.96%
% of portfolio
0.0%
Previous 1.6%
Shares
5 transactions
Others Institutions Holding MLTX
# of Institutions
137Shares Held
58.1MCall Options Held
124KPut Options Held
96.9K-
Bvf Inc San Francisco, CA19.8MShares$745 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$321 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$126 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$105 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$82.5 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.39B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...